Latest filing published 19 Dec 2022 for Surrozen, Inc./DE, €3,678.
Insider track record
No signal scores available.
Geertrui Vanhove: trading record in brief
Geertrui Vanhove discloses dealings in 2 companies, chiefly Insys Therapeutics, Inc. and Surrozen, Inc./DE. Between 2 April 2018 and 15 December 2022, the trades on record add up to 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 19 December 2022, reports a share grant of €3,678 in Surrozen, Inc./DE. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 50 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Geertrui Vanhove
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,578 shares@ US$0.41100.0% of flowCommon StockSEC:0001593968-22-001746:0
- 8,083 shares0Common StockSEC:0001209191-19-025631:1
- 6,000 shares0Common StockSEC:0001209191-19-025631:0
- 8,083 shares0Common StockSEC:0001209191-19-025408:1
- 6,000 shares0Common StockSEC:0001209191-19-025408:0
5 of 5 declarations
